COLD vs REGN
Americold Realty Trust (COLD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
COLD currently screens at market cap $4.75B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the COLD and REGN stock pages for the full models.
Not investment advice.